Revenue
2021
2022
2023
2024
2025
2026
Grace Therapeutics, Inc. (GRCE)
Price$2.26Cached quote
Net income
2019
2020
2021
2022
2023
2024
2025
2026
Free cash flow
2023
2024
2025
Total cash / debt
CashTotal debt
2019
2020
2021
2022
2023
2024
2025
2026
Financial statements
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 · Mar 31 | 2017 · Feb 28 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $196,000 | — | — | — | — | — | — |
| Gross profit | — | — | — | — | $0 | $120,000 | — | — | — | — | — | — |
| Gross margin | — | — | — | — | — | 61.22% | — | — | — | — | — | — |
| Research & development | $2.4M | $9.5M | $4.7M | $10.0M | $5.6M | $4.2M | $16.0M | $29.4M | — | — | — | — |
| Operating expenses | $11.1M | $16.7M | $11.4M | $18.2M | $15.6M | $16.5M | — | — | — | — | — | — |
| Operating income | −$11.1M | −$16.7M | −$12.9M | −$52.2M | −$15.6M | −$16.4M | −$24.4M | −$34.4M | — | — | — | — |
| Operating margin | — | — | — | — | — | −8,377.04% | — | — | — | — | — | — |
| EBITDA | −$11.1M | −$16.7M | −$12.8M | −$52.0M | −$15.6M | −$15.5M | −$22.1M | −$32.1M | — | — | — | — |
| EBITDA margin | — | — | — | — | — | −7,905.61% | — | — | — | — | — | — |
| Net income | −$7.8M | −$9.6M | −$12.9M | −$42.4M | −$9.8M | −$19.7M | −$25.5M | −$39.4M | — | — | — | — |
| Net profit margin | — | — | — | — | — | −10,039.80% | — | — | — | — | — | — |
| Basic EPSper basic share | -$0.47 | -$0.79 | -$1.35 | -$5.71 | -$1.62 | -$7.98 | -$1.80 | -$4.38 | — | — | — | — |
| Diluted EPSper diluted share | -$0.47 | -$0.79 | -$1.35 | -$5.71 | -$1.62 | -$7.98 | -$1.80 | -$4.38 | — | — | — | — |
Owners
Reported shareholders
5.22%of listed shares
Cerity Partners LLC849.06K shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
Cerity Partners LLC | 5.22%849.06K shares |
Eversept Partners, LP | 4.75%772.9K shares |
BANK OF AMERICA CORP /DE/ | 3.04%494.7K shares |
VANGUARD CAPITAL MANAGEMENT LLC | 2.53%411.71K shares |
CITADEL ADVISORS LLC | 2.15%349.74K shares |
CANTOR FITZGERALD, L. P. | 1.23%200K shares |
Maven Securities LTD | 1.23%200K shares |
Birchview Capital, LP | 0.74%120K shares |
TWO SIGMA INVESTMENTS, LP | 0.60%96.89K shares |
JANE STREET GROUP, LLC | 0.55%89.44K shares |
XTX Topco Ltd | 0.44%71.67K shares |
HRT FINANCIAL LP | 0.39%62.69K shares |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.30%49.58K shares |
BlackRock, Inc. | 0.23%37.54K shares |
Rangeley Capital, LLC | 0.16%26K shares |
KESTRA PRIVATE WEALTH SERVICES, LLC | 0.14%23K shares |
UBS Group AG | 0.10%16.78K shares |
Stratos Investment Management, LLC | 0.07%11.16K shares |
BNP PARIBAS FINANCIAL MARKETS | 0.06%10.5K shares |
Scientech Research LLC | 0.06%10.18K shares |
Percentages use 16.27M shares of this listed class outstanding on Jun 30, 2026.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data